What are the latest figures on the hospital-acquired infection control market’s size and projected CAGR?
The hospital-acquired infection control market size has grown steadily in recent years. It will grow from $34.59 billion in 2024 to $35.86 billion in 2025 at a compound annual growth rate (CAGR) of 3.7%. The growth in the historic period can be attributed to increasing antibiotic resistance, growing awareness, stringent regulations, globalization of infectious diseases, patient safety initiatives.
The hospital-acquired infection control market size is expected to see strong growth in the next few years. It will grow to $44.42 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise of multidrug-resistant pathogens, pandemic preparedness, increased surveillance and monitoring, antimicrobial stewardship programs, international collaboration. Major trends in the forecast period include adoption of real-time location systems (RTLS), integration of artificial intelligence (AI) for surveillance, shift towards single-use and disposable devices, emphasis on staff training and education, increased utilization of disinfection technologies.
Get Your Free Sample of The Global Hospital-Acquired Infection Control Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp
What are the key forces behind the hospital-acquired infection control market’s growth in recent years?
The surge in COVID-19 cases is expected to propel the growth of the hospital-acquired infection control market going forward. COVID-19 refers to a viral infection that is caused by the SARS-CoV-2 virus. Due to the COVID-19 pandemic, there is an increase in demand for hospital-acquired infection control products and services to focus on personal hygiene and the production of infection control medical supplies. For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, as of 8th August 2022, the global COVID-19 cases reached 581.6 million. Therefore, the surge in COVID-19 cases is driving the growth of the hospital-acquired infection control market.
What are the major segments of the hospital-acquired infection control market?
The hospital-acquired infection control market covered in this report is segmented –
1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products
2) By Technology: Phenotypic Methods, Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases
4) By Application: Disease Testing, Drug-Resistance Testing
5) By End User: Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users
Subsegments:
1) By Sterilizers: Steam Sterilizers, Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers
2) By Disinfectors: Washer Disinfectors, Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors, Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems, Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps, Filters, Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants, Chlorine-based Disinfectants, Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions, Data Management Software
8) By Other Products: Cleaning Equipment, Air Purification Systems
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report
Which companies dominate the hospital-acquired infection control market?
Major companies operating in the hospital-acquired infection control market include Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.
What major trends will shape the hospital-acquired infection control market during the forecast period?
Major companies operating in the hospital-acquired infection control market are focused on developing new technological solutions, such as AI system to help identify sepsis early to enhance patient outcomes by facilitating rapid diagnosis and treatment. An AI system to help identify sepsis refers to advanced technological solutions that utilize artificial intelligence and machine learning algorithms to detect early signs of sepsis in patients. For instance, in April 2024, Prenosis Inc., a US-based medical clinic, received FDA marketing authorization for the Sepsis ImmunoScore, the first AI-driven system designed to predict sepsis, a life-threatening condition that can lead to severe complications. This innovative tool enhances early detection through real-time data analysis, allowing healthcare professionals to intervene more quickly and effectively. The integration of AI is intended to support medical staff in decision-making rather than replace them, ultimately improving patient outcomes and reducnig healthcare costs.
What are the key regional dynamics of the hospital-acquired infection control market, and which region leads in market share?
The countries covered in the hospital-acquired infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
What Does The Hospital-Acquired Infection Control Market Report 2025 Offer?
The hospital-acquired infection control market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Hospital-acquired infections are acquired during hospital care that is not present before hospital admission. The prevention and control of hospital-acquired infection using various cleaning, sterilization, and disinfection methods refers to hospital-acquired infection control. These infections can be caused by the cross-infection from the surfaces of equipment, the skin of patients, and healthcare staff. Hospital-acquired infection control is used to reduce or eliminate the transmission of illnesses.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7694
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
